Industries > Healthcare > Healthcare Market Access

Healthcare Market Access

SGA offers an amalgamation of strategies, marketing, and competitive intelligence (CI) to pharma, devices, and diagnostic companies who are planning to introduce or check the adequate supply of products amid the market competition and price war.

Blogs | Wearable Tech: A Promise to Revolutionize Healthcare

Why is a strategic healthcare market access plan imperative for your business?

Healthcare market access involves real-time tracking of market nuances as well as reality checks before any product entry, pricing adjustments, product landscaping, or competitor mapping. 

We assist our clients in addressing these concerns before they plan the process. 

  • How to use high-volume data to understand the payer dynamics?  

  • How do we obtain optimal reimbursement?  

  • Where to disseminate market insights?  

  • Why are our peers doing better than us in certain markets?  

  • How to maximize the value of the products/drug/equipment to payers? 

Be it a start-up or an established organization in the market, one can never be too sure of the customer or decision-maker perspective; or what the peers are planning to counter their existing or new product. The only solution to this is real-time data tracking and analysis. SG Analytics (SGA) has been assisting industry clients across the globe with healthcare market access solutions.  

Over the span of our existence, we have supported key Korean and Indonesian enterprises to enter the US and family-run medical diagnostic corporations to enter western Europe. Our credibility, as well as visibility in the market, can be validated by our growing establishments globally. 

Health market access

What We Offer

SGA caters to both native English-speaking and non-English-speaking markets (GCC, CIS, SEA, LATAM). 

SGA facilitates a 360-degree overview of pricing and market access systems as well as assists in tracking how key country pricing systems work before planning a market entry or expansion. 

SGA’s experts on systematic literature review, evaluate, and guide the clients on why setting prices with health economics is not equivalent to defending prices with health economics in each market. 

SGA measures the strength of the client’s clinical profile and the ‘pricing power’ it affords by conducting surveys and primary research with end users. 

SGA employs evidence-based techniques to gain the most accurate feedback while conducting pricing research with payers. Our insights are stronger and better because our pool size of customer interviewees is statistically significant and is driven by in-house panelists. 

SGA analyzes historic payer behavior and current nuances as a significant predictor and explainer of future pricing behavior. Our forecast models are customizable and data-driven – built by industry experts who have more than 15 years of experience in similar fields. 

SGA’s global network assists in evaluating the impact on the client’s product prices around the globe. 

The team of experts at SGA supports your MA teams during the implementation phase and helps in building a sustainable near-term roadmap. 


Industry Leaders

SGA thrives by its brand promise Life is Possible, and is recognized as the most trusted healthcare market research consulting company.

12+ Languages

SGAs analysts are individuals from the best global and premier universities with multilingual expertise in Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (US/UK).

Data-Driven Insights

With our deep domain and business knowledge of the global healthcare value chain and a proven capability of delivering data-driven, actionable, and monetizable insights to healthcare firms, we can offer excellent healthcare market access services to our clients with depth and speed.

End-To-End Solutioning

SGA has an in-house KOL (key opinion leader) capability of more than 700, located across major as well as new markets. This enables us to leverage credible competitive information before our peers.

Who We Work With


Whitepaper Market Entry in 2023

White Papers

Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?

Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...

SGA Whitepaper Blue Ocean Strategy

White Papers

The Blue Ocean Strategy in the Pharmaceutical Industry: What Is the Blue Ocean Strategy About?

Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities....

SGA Healthcare Whitepaper Healthcare Consulting & Analytics

White Papers

What Happens When You Invest in Healthcare Consulting and Analytics?

Healthcare providers who are struggling with high-volume complex data are feeling the need for assistance with data convergence and management. With...

We strongly believe in women power. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.

Our combined experience of pharmaceuticals, medical devices, life sciences, and med-tech ensures high-quality, white-labelled research coverage.